Abstract:Hepatocellular carcinoma (HCC) is one of the common malignant tumors. The prognosis and five-year survival rate of HCC are not promising due to tumor recurrence and metastasis. Exploring markers that contribute to the early diagnosis of HCC, markers for prognostic evaluation of HCC patients, and effective targets for treating HCC patients are in the spotlight of HCC therapy. Zinc Finger CCHC-Type Containing 17 (ZCCHC17) encodes the RNA binding protein ZCCHC17, but its role in HCC is still unclear. Here, 90 paraffin-embedded specimens combined with bioinformatics were used to comprehensively clarify the value of ZCCHC17 in the diagnosis and prognosis of HCC and its potential functions. Paraffin-embedded specimens were used to assess ZCCHC17 protein expression and its correlation with prognosis in 90 HCC patients. the public data sets of HCC patients from TCGA, ICG, and GEO databases were also used for further analysis. It was found that protein and mRNA levels of ZCCHC17 in HCC tissues were significantly higher than those in normal tissues. The abnormally high expression may be related to the abnormal DNA methylation of ZCCHC17 in tumor tissues. The high expression of ZCCHC17 is related to AFP, histologic grade, tumor status, vascular invasion, and pathological stage. Multi-data set analysis showed that patients with high ZCCHC17 expression had a worse prognosis, and multivariate cox regression analysis showed an independent prognostic significance of ZCCHC17. The results of functional analysis, including Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Set Enrichment Analysis (GSEA), indicate that ZCCHC17 is mainly involved in immune regulation. Subsequently, further single-sample gene set enrichment analysis (ssGSEA) showed that the expression of ZCCHC17 was related to the infiltration of immune cells. Importantly, we also analyzed the relationship between ZCCHC17 and immune checkpoint genes, tumor mutation burden (TMB), microsatellite instability (MSI) and TP53 status in HCC patients and evaluated the role of ZCCHC17 in cancer immunotherapy. In summary, ZCCHC17 is a novel marker for the diagnosis and prognostic evaluation of HCC. Concurrently, it regulates immune cells in the tumor microenvironment (TME) of HCC patients, which has a specific reference value for the immunotherapy of HCC.

Decreased Expression of Zinc-Alpha2-glycoprotein in Hepatocellular Carcinoma Associates with Poor Prognosis

Downregulation of AZGP1 by Ikaros and Histone Deacetylase Promotes Tumor Progression Through the PTEN/Akt and CD44s Pathways in Hepatocellular Carcinoma.

Decreased Expression of AZGP1 is Associated with Poor Prognosis in Primary Gastric Cancer

Zinc Finger Protein 296 Promotes Hepatocellular Carcinoma Progression Via Intervening Interaction Between Macrophages and B Cells.

High Expression of AZGP1 is Associated with Poor Prognosis in Colorectal Cancer: a Retrospective Study

Association of Low Zinc Finger Antiviral Protein Expression with Progression and Poor Survival of Patients with Hepatocellular Carcinoma.

Expression Of Zinc-Alpha 2-Glycoprotein (Azgp1) Is Associated With Clinical Prognosis Of Bladder Cancer A Tumor Marker?

Inhibition of zinc-2 glycoprotein in a rat model of hepatocellular carcinoma

ZNF418 Overexpression Protects Against Gastric Carcinoma and Prompts a Good Prognosis

Clinicopathological And Prognostic Implications Of Arginase Expression In Hepatocellular Carcinoma

Increased Expression of Zbp-89 and Its Prognostic Significance in Hepatocellular Carcinoma

Overexpressed Pepsinogen C is Associated with Poor Prognosis in Human Hepatocellular Carcinoma: a Tissue Microarray Study

ZFC3H1 as an Indicator of Poor Prognosis in Hepatocellular Carcinoma: Bioinformatic Analysis and Experimental Verification

Low Levels of Glycoprotein 96 Indicate a Worse Prognosis in Early-Stage Hepatocellular Carcinoma Patients after Hepatectomy.

Reduced Expression of Zdhhc2 is Associated with Lymph Node Metastasis and Poor Prognosis in Gastric Adenocarcinoma

Down-regulation of Long Non-Coding RNA GAS5-AS1 and Its Prognostic and Diagnostic Significance in Hepatocellular Carcinoma

Expressions of Zinc Finger Protein A20, NF-κB P65 Protein, and P-glycoprotein in Primary Hepatocellular Carcinoma

Correlation between the coexpression of zinc finger and SCAN domain-containing protein 31 and transcriptional activator with PDZ-binding motif and prognosis in hepatocellular carcinoma

Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma tumorigenesis via TRIM25

Expression and Clinical Significance of the Novel Long Noncoding RNA ZNF674-AS1 in Human Hepatocellular Carcinoma.

ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma